Arcturus Therapeutics Holdings, Inc. (ARCT)
7.13
-0.12
(-1.66%)
USD |
NASDAQ |
Dec 16, 16:00
7.09
-0.04
(-0.56%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Gross Profit (Quarterly): 13.35M for Sept. 30, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.7497M |
| Novavax, Inc. | 50.65M |
| Sangamo Therapeutics, Inc. | -1.317M |
| Capricor Therapeutics, Inc. | -0.4947M |
| AIM ImmunoTech, Inc. | -0.096M |